Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-007518
Filing Date
2025-03-10
Accepted
2025-03-10 16:28:43
Documents
2
Period of Report
2025-03-01

Document Format Files

Seq Description Document Type Size
1 form3-03102025_080337.html 3  
1 form3-03102025_080337.xml 3 7606
2 ex24-03102025_080339.htm EX-24 3817
  Complete submission text file 0001415889-25-007518.txt   12804
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Purdue David Ryan (Reporting) CIK: 0002057696 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35565 | Film No.: 25724128